M. Khani, A. Mohamadnia, F. Hosseini, Parisa Bayat, N. Bahrami
{"title":"口腔鳞状细胞癌患者外周血VEGF mRNA和miR-494表达的评估","authors":"M. Khani, A. Mohamadnia, F. Hosseini, Parisa Bayat, N. Bahrami","doi":"10.18502/jcr.v6i1.1628","DOIUrl":null,"url":null,"abstract":"Introduction: oral squamous cell carcinoma accounts for 2% of all cancers and also is one of the top 10 causes of death in humans. The goal of this article is to assess changes of VEGF mRNA and miR-494 expression. \nMethod and material: We chose 30 patients with OSCC and 30 healthy people (as a controlled group) and assess the rate of VEGF mRNA and miR-494 expression in peripheral blood with real-time PCR technique. \nFindings: VEGF mRNA marker was positive in 24 out of 30 patients. Also, miR-494 was positive in 20 out of 30 patients. \nResults: overall based on this article's findings, results could count as a diagnostic screening test for OSCC detection in early steps of cancer.","PeriodicalId":52622,"journal":{"name":"Journal of Craniomaxillofacial Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessing VEGF mRNA and miR-494 expression in peripheral blood collected from patients suffering from oral squamous cell carcinoma\",\"authors\":\"M. Khani, A. Mohamadnia, F. Hosseini, Parisa Bayat, N. Bahrami\",\"doi\":\"10.18502/jcr.v6i1.1628\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: oral squamous cell carcinoma accounts for 2% of all cancers and also is one of the top 10 causes of death in humans. The goal of this article is to assess changes of VEGF mRNA and miR-494 expression. \\nMethod and material: We chose 30 patients with OSCC and 30 healthy people (as a controlled group) and assess the rate of VEGF mRNA and miR-494 expression in peripheral blood with real-time PCR technique. \\nFindings: VEGF mRNA marker was positive in 24 out of 30 patients. Also, miR-494 was positive in 20 out of 30 patients. \\nResults: overall based on this article's findings, results could count as a diagnostic screening test for OSCC detection in early steps of cancer.\",\"PeriodicalId\":52622,\"journal\":{\"name\":\"Journal of Craniomaxillofacial Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Craniomaxillofacial Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/jcr.v6i1.1628\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Craniomaxillofacial Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jcr.v6i1.1628","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Assessing VEGF mRNA and miR-494 expression in peripheral blood collected from patients suffering from oral squamous cell carcinoma
Introduction: oral squamous cell carcinoma accounts for 2% of all cancers and also is one of the top 10 causes of death in humans. The goal of this article is to assess changes of VEGF mRNA and miR-494 expression.
Method and material: We chose 30 patients with OSCC and 30 healthy people (as a controlled group) and assess the rate of VEGF mRNA and miR-494 expression in peripheral blood with real-time PCR technique.
Findings: VEGF mRNA marker was positive in 24 out of 30 patients. Also, miR-494 was positive in 20 out of 30 patients.
Results: overall based on this article's findings, results could count as a diagnostic screening test for OSCC detection in early steps of cancer.